Comparative study the use of metformin versus placebo for prophylaxis from gestational diabetes in high risk patients

Not Applicable

• Conditions: Nutritional, Metabolic, Endocrine; Pregnancy and Childbirth; gestational diabetes

• Registration Number: PACTR201503001059248
• Lead Sponsor: Tamer Mamdouh Abdel Dayem

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-06
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

i.Obese patients with body mass index above 30.
ii.Patients with history of gestational diabetes.
iii.Patients with history of gestational diabetes in previous pregnancies.
iv.Patients with multiple gestation.
v.Pateints with family history of gestational diabetes in siblings or type 2 diabetes in parents.
vi.Patients with polycystic ovarian disease

Exclusion Criteria

1-Patients with pre-gestational diabetes
2-Patients with intolerance to metformin e.g. hypersensitivity to the medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
prevention of gestational diabetes

Secondary Outcome Measures

Name	Time	Method
prevention of maternal or fetal complications